Processing body autoantibodies reconsidered

RNA

Volumn 12, Issue 5, 2006, Pages 707-709

  Bloch, Donald B ^a,b   Gulick, Tod ^a,b   Bloch, Kenneth D ^a,b   Yang, Wei Hong ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoantigen; mRNA decay; mRNA processing body; RISC complex

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; MESSENGER RNA; PROTEIN; PROTEIN AGO2; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SERUM;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOBLOTTING; INDOLES; LIVER NEOPLASMS; NUCLEAR PROTEINS; PEPTIDE INITIATION FACTORS; RNA, MESSENGER; RNA-INDUCED SILENCING COMPLEX;

EID: 33646196855     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.17406     Document Type: Article

References (14)

1. Bloch, D.B., Rabkina, D., Quertermous, T., and Bloch, K.D. 1994. The immunoreactive region in a novel autoantigen contains a nuclear localization sequence. Clin. Immunol. Immunopathol. 72: 380-389.
2. Bloch, D.B., Yu, J.H., Yang, W.H., Graeme-Cook, F., Lindor, K.D., Viswanathan, A., Bloch, K.D., and Nakajima, A. 2005. The cytoplasmic dot staining pattern is detected in a subgroup of patients with primary biliary cirrhosis. J. Rheumatol. 32: 477-483.
3. Cougot, N., Babajko, S., and Seraphin, B. 2004. Cytoplasmic foci are sites of mRNA decay in human cells. J. Cell Biol. 165: 31-40.
4. Eystathioy, T., Chan, E.K., Tenenbaum, S.A., Keene, J.D., Griffith, K., and Fritzler, M.J. 2002. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol. Biol. Cell 13: 1338-1351.
5. Eystathioy, T., Chan, E.K., Takeuchi, K., Mahler, M., Luft, L.M., Zochodne, D.W., and Fritzler, M.J. 2003a. Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182. J. Mol. Med. 81: 811-818.
6. Eystathioy, T., Jakymiw, A., Chan, E.K., Seraphin, B., Cougot, N., and Fritzler, M.J. 2003b. The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA 9: 1171-1173.
7. Fenger-Gron, M., Fillman, C., Norrild, B., and Lykke-Andersen, J. 2005. Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol. Cell 20: 905-915.
8. Jakymiw, A., Lian, S., Eystathioy, T., Li, S., Satoh, M., Hamel, J.C., Fritzler, M.J., and Chan, E.K. 2005. Disruption of GW bodies impairs mammalian RNA interference. Nat. Cell Biol. 7: 1167-1174.
9. Liu, J., Rivas, F.V., Wohlschlegel, J., Yates, J.R., Parker, R., and Hannon, G.J. 2005a. A role for the P-body component GW182 in microRNA function. Nat. Cell Biol. 7: 1161-1166.
10. Liu, J., Valencia-Sanchez, M.A., Hannon, G.J., and Parker, R. 2005b. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell Biol. 7: 719-723.
11. Sen, G.L. and Blau, H.M. 2005. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat. Cell Biol. 7: 633-636.
12. Sheth, U and Parker, R. 2003. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300: 805-808.
13. Yang, Z., Jakymiw, A., Wood, M.R., Eystathioy, T., Rubin, R.L., Fritzler, M.J., and Chan, E.K. 2004. GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation. J. Cell Sci. 117: 5567-5578.
14. Yu, J.H., Yang, W.H., Gulick, T., Bloch, K.D., and Bloch, D.B. 2005. Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA 11: 1795-1802.